Cardiovascular and interventional radiology
-
Cardiovasc Intervent Radiol · Jun 2015
Randomized Controlled Trial Comparative StudyComparison of ultrasound-guided and fluoroscopy-assisted antegrade common femoral artery puncture techniques.
To prospectively compare the procedural time and complication rates of ultrasound-guided and fluoroscopy-assisted antegrade common femoral artery (CFA) puncture techniques. ⋯ Ultrasound-guided technique is faster and safer for antegrade CFA puncture when compared to the fluoroscopic-assisted technique alone.
-
Cardiovasc Intervent Radiol · Apr 2015
Case ReportsSuccessful transumbilical retrieval of a broken umbilical venous catheter in a 1-day-old new born baby.
We describe successful transumbilical retrieval of a broken umbilical venous catheter in a 37-week gestation, 2530-g female infant on her 1 day of life under fluoroscopic guidance.
-
To report the technical results and imaging findings of intranodal lymphangiogram (INL). ⋯ INL succeeded in all patients. Lipiodol leaked into the vein through a lymphaticovenous anastomosis at the femoral or pelvic region in all patients.
-
Cardiovasc Intervent Radiol · Oct 2014
Randomized Controlled TrialA randomized, double-blind, placebo-controlled study of preemptive oral oxycodone with morphine patient-controlled anesthesia for postoperative pain management in patients undergoing uterine artery embolization for symptomatic uterine fibroids.
To evaluate the analgesic efficacy of oral premedication of oxycodone in a group of patients undergoing elective uterine artery embolization under sedation for fibroid disease. ⋯ The addition of preprocedural oral oxycodone to morphine patient-controlled analgesia does not offer any analgesic advantage to patients having uterine artery embolization and may cause a greater incidence of nausea and vomiting.
-
Cardiovasc Intervent Radiol · Oct 2014
Randomized Controlled TrialEnhancing ablation effects of a microbubble-enhancing contrast agent ("SonoVue") in the treatment of uterine fibroids with high-intensity focused ultrasound: a randomized controlled trial.
To evaluate the role of the ultrasound contrast agent SonoVue in enhancing the ablation effects of ultrasound-guided high-intensity focused ultrasound (HIFU) on uterine fibroids. ⋯ Based on the results of this randomized controlled trial, SonoVue could be safely used to enhance the effects of HIFU treatment for uterine fibroids.